EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias

Scott J Sherman, Miguel Estevez, Ari B Magill, Torsten Falk

Case Reports in Neurology · 26.02.2016 · 8 (1) · 53-58

DOI: 10.1159/000444278 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Neurology, online erschienen am 26.02.2016. Verfasst von Scott J Sherman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Arizona, Tucson, Ariz., USA. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine is an FDA-approved drug with a known safety profile. Low-dose subanesthetic intravenous ketamine infusion treatment has led to long-term reduction of treatment-resistant depression and of chronic pain states. We report on low-dose subanesthetic intravenous ketamine infusion treatment in Parkinson's disease (PD) patients by 5 case studies and show a long-lasting therapeutic benefit to reduce L-DOPA-induced dyskinesia (LID), improve on time, and reduce depression. Based on the literature we hypothesize that low-dose ketamine may act as a ‘chemical deep brain stimulation', by desynchronizing hypersynchronous oscillatory brain activity, including in the basal ganglia and the motor cortex. The presented PD case reports indicate tolerability, safety and long-term beneficial effects of low-dose ketamine infusion that should be further investigated in a properly controlled prospective clinical trial for treatment of LID, as well as the prevalent nonmotor features pain and depression in PD patients.

Schlagwörter

Stichwörter der Autor:innen

DepressionHypersynchronyLevodopaNMDA receptorsPainParkinson's disease

Autor:innen und Institutionen

  • Department of Neurology, University of Arizona, Tucson, Ariz., USA.
  • Neurometrica, LLC, Eugene, Oreg., USA.

Zitieren

APA

Sherman, S. J., Estevez, M., Magill, A. B., & Falk, T. (2016). Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias. Case Reports in Neurology, 8(1), 53-58. https://doi.org/10.1159/000444278

Vancouver

Sherman SJ, Estevez M, Magill AB, Falk T. Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias. Case Reports in Neurology. 2016;8(1):53-58. doi:10.1159/000444278

BibTeX
@article{Sherman2016,
  author = {Sherman, Scott J and Estevez, Miguel and Magill, Ari B and Falk, Torsten},
  title = {Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias},
  journal = {Case Reports in Neurology},
  year = {2016},
  volume = {8},
  number = {1},
  pages = {53--58},
  doi = {10.1159/000444278}
}
Kostenlos starten →